KERENDIA
KERENDIA
Approved
DIN Number
02531925
Drug Class
Human
Market Date
Nov 22, 2022
Company
HC
Bayer Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02531925
AIG Number0164141002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C03DA05 FINERENONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
FINERENONEActive
Strength: 20 MG
Monograph: FINERENONE